Notes / Company

Procter & Gamble Health Ltd.

PGHL BSE 500126 ISIN INE199A01012 Pharmaceuticals

Fundamentals

Market cap: ₹10,313 cr
P/E: 35.14×
ROE: 43.66%
Debt / equity: 0.00
Div yield: 2.21%
52-week range: 4707.00 — 6739.00

The timeline — 1 note on Procter & Gamble Health Ltd.

May 2026

26 May 26 · 5:31 PM IST Brief

Brief · Earnings · Mid cap

Procter & Gamble Health posts 30% profit growth for FY26

The company closed the year with ₹327 crore in profit as Q4 momentum accelerated. Shareholders will receive a total dividend of ₹205 per share.

Verify on exchange BSE filings for PGHL NSE filings for PGHL